Kumada-Tamao-Corriu Type Reaction of Aromatic Bromo- and Iodoamines with Grignard Reagents.

The first example of the Kumada-Tamao-Corriu type reaction of unprotected bromoanilines with Grignard reagents is described. The method uses a palladium source and a newly designed Buchwald-type ligand as the catalytic system. Secondary and tertiary bromo- and iodoamines were also successfully coupled to alkyl Grignard reagents. The products of the competitive ß-hydride elimination reaction were successfully reduced using a highly efficient electron-deficient phosphine ligand (BPhos). Mechanistic considerations allowed us to establish that the less electron-rich phosphine ligands stabilize the transition state much better than the electron-rich ones; hence, they increase the reaction yield and reduce the amount of ß-hydride elimination products. The developed method proved to be tolerant of many functional groups and can be applied to many different aromatic bromo- and iodoamines. Multigram synthesis of p-toluidine from 4-bromoaniline was achieved with a palladium catalyst loading of only 0.03 mol%.

Assessing the Interactions of Statins with Human Adenylate Kinase Isoenzyme 1: Fluorescence and Enzyme Kinetic Studies.

Statins are the most effective cholesterol-lowering drugs. They also exert many pleiotropic effects, including anti-cancer and cardio- and neuro-protective. Numerous nano-sized drug delivery systems were developed to enhance the therapeutic potential of statins. Studies on possible interactions between statins and human proteins could provide a deeper insight into the pleiotropic and adverse effects of these drugs. Adenylate kinase (AK) was found to regulate HDL endocytosis, cellular metabolism, cardiovascular function and neurodegeneration. In this work, we investigated interactions between human adenylate kinase isoenzyme 1 (hAK1) and atorvastatin (AVS), fluvastatin (FVS), pravastatin (PVS), rosuvastatin (RVS) and simvastatin (SVS) with fluorescence spectroscopy. The tested statins quenched the intrinsic fluorescence of hAK1 by creating stable hAK1-statin complexes with the binding constants of the order of 104 M-1. The enzyme kinetic studies revealed that statins inhibited hAK1 with significantly different efficiencies, in a noncompetitive manner. Simvastatin inhibited hAK1 with the highest yield comparable to that reported for diadenosine pentaphosphate, the only known hAK1 inhibitor. The determined AK sensitivity to statins differed markedly between short and long type AKs, suggesting an essential role of the LID domain in the AK inhibition. Our studies might open new horizons for the development of new modulators of short type AKs.

Electrosynthesis of 1,2,4-Triazolium Tetrafluoroborates.

The synthesis of 1,2,4-triazolium tetrafluoroborates under electrochemical conditions is reported. The reaction is performed with stoichiometric amounts of HBF4, which converts starting materials to their corresponding cationic forms due to protonation. As a result, sufficient conductivity is gained in MeOH, CD3OD, and EtOH, and no additional supporting electrolyte is required. Agrochemical fungicide, (±)-triticonazole (1), is transformed in this manner into 2a, an O-methylated potential intermediate involved in the metabolism of 1, in 42% yield on a gram scale.

Synthesis of xanthohumol and xanthohumol-d3 from naringenin.

A six-step synthesis of xanthohumol (1a) and its d3-derivative (1b) from easily accessible naringenin is reported. The prenyl side chain was introduced by Mitsunobu reaction followed by the europium-catalyzed Claisen rearrangement and base-mediated opening of chromanone gave access to an α,ß-conjugated ketone system. Compound 1b was used as an internal standard in stable isotope dilution assays of 1a in two Polish beers.